Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Amendment: Biohit Oyj Managers' Transactions

Posted on: 27 Aug 18

BIOHIT OYJ           AMENDMENT: MANAGERS’ TRANSACTIONS                              
27 AUGUST 2018  At 13.00 local time (EET)

Biohit Oyj: Managers' Transactions

Person subject to the notification requirement
Ilari Patrakka
Position:                                Other Senior Management

Issuer:                                   Biohit Oyj
LEI:                                        74370089ATTSNBXJVT29

Notification type:                 AMENDMENT
Reference number:              74370089ATTSNBXJVT29_20180824112013_5

Transaction date:                 2018-08-22
Venue:                                   OFF-EXCHANGE TRANSACTIONS (XOFF)

Nature of the transaction:    SUBSCRIPTION 
(X) Linked to stock option programme
Instrument type:                    SHARE
ISIN:                                        FI4000219324

Transaction details
Volume: 1,116 
Unit price: 2.2766 EUR

Aggregated transactions
Volume: 1,116 
Volume weighted average price: 2.2766 EUR

Biohit Oyj

Semi Korpela

For additional information: 
CEO Semi Korpela,
Biohit Oyj
p. +358 9 773 861


Last updated on: 27/08/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.